403 related articles for article (PubMed ID: 18724539)
1. The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia.
Robinson DW; Eisenberg DF; Cella D; Zhao N; de Boer C; DeWitte M
J Support Oncol; 2008; 6(6):283-90. PubMed ID: 18724539
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.
Wiedenmann B; Malfertheiner P; Friess H; Ritch P; Arseneau J; Mantovani G; Caprioni F; Van Cutsem E; Richel D; DeWitte M; Qi M; Robinson D; Zhong B; De Boer C; Lu JD; Prabhakar U; Corringham R; Von Hoff D
J Support Oncol; 2008 Jan; 6(1):18-25. PubMed ID: 18257397
[TBL] [Abstract][Full Text] [Related]
3. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.
Smyth EN; Shen W; Bowman L; Peterson P; John W; Melemed A; Liepa AM
Health Qual Life Outcomes; 2016 Mar; 14():52. PubMed ID: 27016084
[TBL] [Abstract][Full Text] [Related]
5. Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).
Romanus D; Kindler HL; Archer L; Basch E; Niedzwiecki D; Weeks J; Schrag D;
J Pain Symptom Manage; 2012 Feb; 43(2):205-17. PubMed ID: 22104618
[TBL] [Abstract][Full Text] [Related]
6. Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial.
Del Fabbro E; Dev R; Hui D; Palmer L; Bruera E
J Clin Oncol; 2013 Apr; 31(10):1271-6. PubMed ID: 23439759
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens.
Wainberg ZA; Feeney K; Lee MA; Muñoz A; Gracián AC; Lonardi S; Ryoo BY; Hung A; Lin Y; Bendell J; Hecht JR
BMC Cancer; 2020 Jul; 20(1):633. PubMed ID: 32641104
[TBL] [Abstract][Full Text] [Related]
8. Objective outcome measures of quality of life.
Burris HA
Oncology (Williston Park); 1996 Nov; 10(11 Suppl):131-5. PubMed ID: 8953600
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.
Maréchal R; Demols A; Gay F; De Maertelaere V; Arvanitaki M; Hendlisz A; Van Laethem JL
Oncology; 2007; 73(1-2):41-51. PubMed ID: 18334830
[TBL] [Abstract][Full Text] [Related]
10. Nutritional status of patients with locally advanced pancreatic cancer: a pilot study.
Ferrucci LM; Bell D; Thornton J; Black G; McCorkle R; Heimburger DC; Saif MW
Support Care Cancer; 2011 Nov; 19(11):1729-34. PubMed ID: 20967470
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients.
Wallengren O; Lundholm K; Bosaeus I
Support Care Cancer; 2013 Jun; 21(6):1569-77. PubMed ID: 23314651
[TBL] [Abstract][Full Text] [Related]
12. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.
Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E
J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820
[TBL] [Abstract][Full Text] [Related]
13. Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
Gourgou-Bourgade S; Bascoul-Mollevi C; Desseigne F; Ychou M; Bouché O; Guimbaud R; Bécouarn Y; Adenis A; Raoul JL; Boige V; Bérille J; Conroy T
J Clin Oncol; 2013 Jan; 31(1):23-9. PubMed ID: 23213101
[TBL] [Abstract][Full Text] [Related]
14. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Von Hoff DD; Ervin T; Arena FP; Chiorean EG; Infante J; Moore M; Seay T; Tjulandin SA; Ma WW; Saleh MN; Harris M; Reni M; Dowden S; Laheru D; Bahary N; Ramanathan RK; Tabernero J; Hidalgo M; Goldstein D; Van Cutsem E; Wei X; Iglesias J; Renschler MF
N Engl J Med; 2013 Oct; 369(18):1691-703. PubMed ID: 24131140
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.
Gresham G; Placencio-Hickok VR; Lauzon M; Nguyen T; Kim H; Mehta S; Paski S; Pandol SJ; Osipov A; Gong J; Jamil LH; Nissen N; Lo SK; Hendifar AE
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1959-1968. PubMed ID: 34609081
[TBL] [Abstract][Full Text] [Related]
16. [Multi-center trial of gemcitabine for 49 patients with advanced pancreatic cancer].
Sumii T; Funakoshi A; Ito T; Mizumoto K; Tanaka M; Migita Y; Sakai T; Shinozaki H; Yamaguchi H; Niyahara T; Muranaka T; Eriguchi N; Ueki T;
Gan To Kagaku Ryoho; 2003 Jul; 30(7):971-6. PubMed ID: 12894712
[TBL] [Abstract][Full Text] [Related]
17. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.
Philip PA; Lacy J; Portales F; Sobrero A; Pazo-Cid R; Manzano Mozo JL; Kim EJ; Dowden S; Zakari A; Borg C; Terrebonne E; Rivera F; Sastre J; Bathini V; López-Trabada D; Asselah J; Saif MW; Shiansong Li J; Ong TJ; Nydam T; Hammel P
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):285-294. PubMed ID: 31953079
[TBL] [Abstract][Full Text] [Related]
18. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.
Fearon KC; Voss AC; Hustead DS;
Am J Clin Nutr; 2006 Jun; 83(6):1345-50. PubMed ID: 16762946
[TBL] [Abstract][Full Text] [Related]
19. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
Chang VT; Xia Q; Kasimis B
J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer.
Rao AD; Sugar EA; Chang DT; Goodman KA; Hacker-Prietz A; Rosati LM; Columbo L; O'Reilly E; Fisher GA; Zheng L; Pai JS; Griffith ME; Laheru DA; Iacobuzio-Donahue CA; Wolfgang CL; Koong A; Herman JM
Pract Radiat Oncol; 2016; 6(6):417-424. PubMed ID: 27552809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
